Search results
Results from the WOW.Com Content Network
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.
The company was named after Jude the Apostle, the patron saint of lost causes. [4] St. Jude Medical was founded in 1976 and went public in 1977, [4] [5] and the company has been listed in the Fortune 500 every year since 2010. [6] The company was acquired by Abbott Laboratories in January 2017. [7] [8]
In August 2007 the company donated $2.5 million to UC-Irvine's Department of Ophthalmology to boost the university's planned Eye Institute. [10] On February 26, 2009, Abbott Laboratories announced that it had completed its acquisition of Advanced Medical Optics (AMO) in a $2.8 billion deal. AMO had become a wholly owned subsidiary of Abbott and ...
The company packaged its U.S. drug portfolio and pipeline into AbbVie , leaving it with its medical device and equipment products and responsibility for 1 Year After the Spin-Off, Abbott ...
Here's the current margin snapshot for Abbott Laboratories over the trailing 12 months: Gross margin is 60.0%, while operating margin is 16.5% and net margin is 12.2%.
Add Abbott Laboratories to My Watchlist. At the time thisarticle was published Jim Royal, Ph.D., owns no shares of any company mentioned here. The Motley Fool owns shares of Medtronic and Abbott ...
In February 2015, in a tax inversion, the company acquired the generic drugs business in developed markets of Abbott Laboratories for $5.3 billion in stock. [64] [65] Also in February 2015, the company acquired Mumbai-based Famy Care and expand its presence in the market for women's contraceptives at about $750 million. [66] [67]
Phillips retained about a third of the company, which he sold in 2004. [1] [2] In 2005, EAS was purchased by Abbott Laboratories for approximately $320 million in a cash-for-stock transaction and existed as a solely-owned division of Abbott. [3] The refreshed product line focused on sports bars, drink mixes, and similar products.